SCA Pharmaceuticals has appointed Scott Luce as Chief Commercial Officer.
Luce has more than 30 years of leadership experience accelerating global sales and profit growth in pharmaceuticals, biologics, and medical devices by driving innovation and customer care. Notably, Luce has significant background in bringing products and services to the hospital sector.
Most recently, Luce has been an operating partner with The Vistria Group, where he helped develop and execute its health care sector investment strategy. Prior to joining The Vistria Group, Luce held numerous positions in general management, sales and marketing, and business development with both Abbott and Baxter.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
“We are very excited to add this strategic role to our leadership team,” said Milton Boyer, CEO of SCA Pharma. “Scott’s vast experience in leadership, operational performance and specialty pharmaceuticals will allow SCA Pharma to focus on meeting market demands for the products and services we provide to hospital pharmacies.”
“I am very excited to join the SCA Pharma team,” said Luce. “The critical role that SCA Pharma has played in providing hospitals with a reliable source of safe, ready-to-use product has never been more significant than it is today. We will continue to be customer-centric in our delivery of products and services.”
Luce earned a bachelor’s of science degree in marketing from Indiana University and a master’s of business administration from Lake Forest Graduate School of Management.